97 results
PRER14A
ANIK
Anika Therapeutics Inc.
5 Apr 23
Preliminary revised proxy
11:19am
NEOs (excepting certain new- hire awards of time-vesting stock options)
Balance short-term and long-term incentives
Require NEOs to own significant … received a special grant of stock options at time of her hire as full-time President and Chief Executive Officer in April 2020. These options vested based
DEFA14A
ANIK
Anika Therapeutics Inc.
1 Jun 22
Additional proxy soliciting materials
12:08pm
significant competition for attracting experienced employees in the life science labor market; failure to hire and retain key personnel could have
DEFA14A
iu90al1dpdjm3
9 May 22
Additional proxy soliciting materials
4:00pm
8-K
EX-10.1
jmzfj5htkkmh5r695
5 Aug 20
Anika Appoints Michael Levitz as Chief Financial Officer
5:04pm
8-K
EX-10.1
3dmsu8v7
29 Apr 20
Anika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer
4:15pm
8-K
EX-10.1
4ek730dhvahzcnx3s
2 Mar 20
Departure of Directors or Certain Officers
4:05pm
8-K
EX-2.1
5qk02e lot77gxapf
7 Jan 20
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-2.2
56wvoglnwzzfj4tags
7 Jan 20
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.2
ctxf45p2vjwfyta gh
10 Jul 19
Departure of Directors or Certain Officers
4:05pm